Motor function and safety after allogeneic cord blood and cord tissue‐derived mesenchymal stromal cells in cerebral palsy: An open‐label, randomized trial

AIM: To evaluate safety and motor function after treatment with allogeneic umbilical cord blood (AlloCB) or umbilical cord tissue‐derived mesenchymal stromal cells (hCT‐MSC) in children with cerebral palsy (CP). METHOD: Ninety‐one children (52 males, 39 females; median age 3 years 7 months [range 2–...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jessica M., Case, Laura E., McLaughlin, Colleen, Burgess, Alicia, Skergan, Natalie, Crane, Sydney, Jasien, Joan M., Mikati, Mohamad A., Troy, Jesse, Kurtzberg, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796267/
https://www.ncbi.nlm.nih.gov/pubmed/35811372
http://dx.doi.org/10.1111/dmcn.15325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796267/
https://www.ncbi.nlm.nih.gov/pubmed/35811372
http://dx.doi.org/10.1111/dmcn.15325

Ejemplares similares